Evidence map›Paper›PMID 39883646›Full record

ArticlePloS one2025

Net buffer load during regional citrate anticoagulated continuous renal replacement therapy.

Innas Forsal, Dominique Pouchoulin, Viktoria Roos, Jorge Echeverri, Marcus Ewert Broman

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trial
  2. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Innas ForsalBaxter International Inc., Lund, Sweden.ORCID 0009-0008-4387-2163
Dominique PouchoulinBaxter International Inc., Meyzieu, France.
Viktoria RoosBaxter International Inc., Lund, Sweden.
Jorge EcheverriBaxter International Inc., Deerfield, Massachusetts, United States of America.
Marcus Ewert BromanSkåne University Hospital, Lund, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRegionally anticoagulated continuous renal replacement therapy with citrate is the first choice for critically ill patients with acute kidney injury. If citrate that reaches the patient exceeds the metabolic capacity, metabolic alkalosis will follow. Bicarbonate from the treatment fluids will also reach the patient and add to the bicarbonate load. Net buffer load is a parameter calculated by the dialysis machine software from the treatment fluid contents, the fluid flows and the filter properties. Each time the treatment settings are altered the net buffer load will be re-calculated. This parameter is integrated as a static safety parameter in the Prismax version 3 software, and will guide the operator on a possible development of metabolic alkalosis with the current settings.

methodsAlgorithms for estimating the net buffer load were developed. Hourly clinical data from electronic medical records from 60 patients' continuous renal replacement treatments at the Adult Intensive Care Unit, Skåne University Hospital, Lund, Sweden was used to simulate net buffer load. The relation between net buffer load and acid base status at steady state was evaluated. Net buffer load was also calculated from three previous studies for comparison to our present cohort.

resultsThe mean net buffer load was +0.09 ±0.04 mmol/h/kg in the present cohort, and comparable to historic cohorts from literature. We could not establish a correlation to steady state arterial bicarbonate. The pre blood pump citrate containing replacement fluid flow rate was affecting net buffer load most of all parts of the dialysis circuit, with a r2 Pearson correlation coefficient of 0.65 (p<0.001).

conclusionThe net buffer load parameter can alert the operator on the expected impact of the dialysis circuit on patient's acid base status. It was possible to calculate realistic net buffer load values during 60 CRRT treatments.

Indexed as

Acute Kidney InjuryAnticoagulantsCitric AcidContinuous Renal Replacement TherapyAgedAlgorithmsBicarbonatesBuffersFemaleHumansMaleMiddle AgedRenal Replacement TherapyAnticoagulantsBicarbonatesBuffersCitric Acid

Identifiers

PMID39883646
PMCPMC11781738

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.